Revolutionize cancer care with Aptamers.

Revolutionize cancer care with Aptamers.

Revolutionize cancer care with Aptamers.

Revolutionize cancer care with Aptamers.

Aptamers

Aptamers

Aptamers

Aptamers

These small, single-stranded DNA or RNA molecules are your unsung heroes in the battle against cancer. Their ability to bind to molecules with high specificity and affinity make them a powerful weapon in diagnostics and therapeutics.

Aptamers in Action

Aptamers in Action

Aptamers in Action

Aptamers in Action

Unleash the power of aptamers on the cancer front! Use them as diagnostic tools to identify cancer biomarkers or as therapeutic agents to target cancer cells directly. No more playing hide and seek with cancer scores.

From Macugen to Somavern, these molecular marvels are making a name for themselves with FDA approval in the world of targeted therapy. Stay tuned for more aptamers swooping into the cancer care scene.

Aptamer Showcase

Aptamer Showcase

Aptamer Showcase

Aptamer Showcase

10

10

Aptamers Approved

100+

100+

Cancer Types

85%

85%

Accuracy Rate

January 15, 2022

FDA Approval: Macugen

FDA Approval: Macugen

FDA Approval: Macugen

FDA Approval: Macugen

June 20, 2022

Phase 2 Trial: Somavern

Phase 2 Trial: Somavern

Phase 2 Trial: Somavern

Phase 2 Trial: Somavern

November 5, 2023

Breakthrough Research in Custom Aptamers

Breakthrough Research in Custom Aptamers

Breakthrough Research in Custom Aptamers

Breakthrough Research in Custom Aptamers

February 1, 2024

Global Oncology Summit

Global Oncology Summit

Global Oncology Summit

Global Oncology Summit






Join Us

Join Us

Join Us

Join Us

Are you ready to dive into the future of cancer diagnosis and treatment with aptamers? Don’t miss a beat.

Stay Updated

© 2023 Aptamers For Cancer